Blake Belanger

Blake Belanger has extensive experience in forecasting and analytics within the biotechnology and healthcare sectors, most recently serving as Senior Director at Gilead Sciences from November 2018 to May 2022, where roles included Director of Forecasting and Associate Director of Commercial FP&A focused on HIV. Prior to this tenure, Blake held positions such as Senior Analyst in Market Strategy and Analysis at Kaiser Foundation Health Plan, Scientist at Oxford BioTherapeutics, and Research Associate II at Medarex. Educational qualifications include an M.B.A. in Marketing and Finance from the University of California, Davis, and a B.S. in Biological Sciences from the same institution.